arrow
Y

Yangxun Pan

Sun Yat-sen University Cancer Center
H指数:17
被引数:809

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Online risk scores for pre- and postoperative prediction of early recurrence in hepatocellular carcinoma patients undergoing conversion liver resection after tyrosine kinase inhibitors and immune checkpoint inhibitors therapy

行转化性肝切除的肝细胞癌患者经酪氨酸激酶抑制剂和免疫检查点抑制剂治疗后,用于术前和术后早期复发的在线风险评分

2025-06-160
PRE
YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment (vol 23, 186, 2024)

YTHDF2在肿瘤周肝细胞中通过CX3CL1介导的CD8+ T细胞募集介导化疗诱导的抗肿瘤免疫应答(卷23,186,2024)

2025-01-310
OA
Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study
2024-04-286
OAAI
Laparoscopic Hepatectomy versus Open Hepatectomy After Conversion Therapy Using Transarterial Chemoembolization or Hepatic Arterial Infusion Chemotherapy for Patients with Initially Unresectable Hepatocellular Carcinoma

对于最初无法切除的肝细胞癌患者,使用经动脉化疗栓塞或肝动脉灌注化疗进行转化治疗后的腹腔镜肝切除术与开腹肝切除术的比较

2023-07-011
OAAI
Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center study
2023-04-267
OAAI